Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2024 Earnings

6AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-0.45

-0.2

0.04

0.29

Details

Expected EPS

0.17767

Actual EPS

0.2

Surprise EPS

0.02

Surprise Percent

+12.57%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of 0.2 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.